Etiology and Management of Lack or Loss of Response to Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease

The management of patients with moderate to severe inflammatory bowel disease was transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a considerable number of patients do not respond to anti-TNF induction therapy (primary nonresponse) or lose response to treatment...

Full description

Saved in:
Bibliographic Details
Published in:Gastroenterol Hepatol (N Y)
Main Authors: Fine, Sean, Papamichael, Kostantinos, Cheifetz, Adam S.
Format: Artigo
Language:Inglês
Published: Millennium Medical Publishing 2019
Subjects:
Column
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935028/
https://ncbi.nlm.nih.gov/pubmed/31892912
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items